L Arnould

Author PubWeight™ 38.62‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: implications for tumorigenesis. Cancer Res 2000 3.06
2 Retention and attrition during the preparation phase and after start of antiretroviral treatment in Thyolo, Malawi, and Kibera, Kenya: implications for programmes? Trans R Soc Trop Med Hyg 2011 1.50
3 Pre-operative systemic (neo-adjuvant) therapy with trastuzumab and docetaxel for HER2-overexpressing stage II or III breast cancer: results of a multicenter phase II trial. Ann Oncol 2005 1.33
4 Calibration of immunohistochemistry for assessment of HER2 in breast cancer: results of the French multicentre GEFPICS study. Histopathology 2003 1.23
5 Malignant extraovarian endometriosis: a review. Eur J Surg Oncol 2005 1.23
6 Increase of CD4+ CD25+ regulatory T cells in the peripheral blood of patients with metastatic carcinoma: a Phase I clinical trial using cyclophosphamide and immunotherapy to eliminate CD4+ CD25+ T lymphocytes. Clin Exp Immunol 2007 1.20
7 T-bet expression in intratumoral lymphoid structures after neoadjuvant trastuzumab plus docetaxel for HER2-overexpressing breast carcinoma predicts survival. Br J Cancer 2011 1.14
8 CD4+ CD56+ cutaneous neoplasms: a distinct hematological entity? Groupe Français d'Etude des Lymphomes Cutanés (GFELC). Am J Surg Pathol 1999 1.10
9 Nitric oxide synthase in human breast cancer is associated with tumor grade, proliferation rate, and expression of progesterone receptors. Lab Invest 1999 1.07
10 Demographic characteristics and opportunistic diseases associated with attrition during preparation for antiretroviral therapy in primary health centres in Kibera, Kenya. Trop Med Int Health 2011 1.07
11 Antiretroviral therapy for HIV prevention: many concerns and challenges, but are there ways forward in sub-Saharan Africa? Trans R Soc Trop Med Hyg 2010 1.05
12 Changes in 18F-FDG tumor metabolism after a first course of neoadjuvant chemotherapy in breast cancer: influence of tumor subtypes. Ann Oncol 2012 0.99
13 [Metastatic renal cell carcinoma to the thyroid gland: report of seven cases and review of the literature]. Ann Chir 2004 0.96
14 Gene expression profile and response to trastuzumab-docetaxel-based treatment in breast carcinoma. Br J Cancer 2009 0.94
15 Concurrent lymphoma and metastatic breast carcinoma in the axillary, confounding sentinel lymph-node biopsy. Eur J Surg Oncol 2004 0.94
16 FOXP3 expression in cancer cells and anthracyclines efficacy in patients with primary breast cancer treated with adjuvant chemotherapy in the phase III UNICANCER-PACS 01 trial. Ann Oncol 2012 0.90
17 Pathological complete response and survival according to the level of HER-2 amplification after trastuzumab-based neoadjuvant therapy for breast cancer. Br J Cancer 2010 0.88
18 The role of surgery and treatment trends in uterine sarcoma. Eur J Surg Oncol 2005 0.86
19 Long-term follow-up of HER2-overexpressing stage II or III breast cancer treated by anthracycline-free neoadjuvant chemotherapy. Ann Oncol 2010 0.85
20 Cure of colon cancer metastasis in rats with the new lipid A OM 174. Apoptosis of tumor cells and immunization of rats. Clin Exp Metastasis 1999 0.84
21 Early incidence of adriamycin treatment on cardiac parameters in the rat. Can J Physiol Pharmacol 1994 0.83
22 Report of a primary lymphoma of the conjunctiva. A lymphoma of MALT origin? Pathol Res Pract 1991 0.83
23 Microstructural factors controlling the survival of food-borne pathogens in porous media. Int J Food Microbiol 2001 0.81
24 Implication of the Epstein-Barr virus in the progression of chronic lymphocytic leukaemia/small lymphocytic lymphoma to Hodgkin-like lymphomas. Anticancer Res 1998 0.81
25 Genital carcinoma secondary to pagetoid spread from a pagetoid urothelial carcinoma in-situ. Histopathology 1998 0.81
26 [A case of liver angiosarcoma arising in a pre-existing cavernous hemangioma]. Ann Pathol 1990 0.80
27 [Malignant tumours arising in extraovarian endometriosis: three case reports and review of the literature]. Ann Chir 2004 0.80
28 Expression of inducible nitric oxide synthase in tumors in relation with their regression induced by lipid A in rats. Int J Cancer 1999 0.80
29 [Adjuvant breast cancer: which clinical and pathological characteristics in 2007?]. Bull Cancer 2010 0.79
30 Automated morphometric estimation of liver steatosis. Microsc Acta Suppl 1979 0.78
31 Treatment of idiopathic retroperitoneal fibrosis with tamoxifen. Nephrol Dial Transplant 1997 0.78
32 Systemic mast cell disease associated with hairy cell leukaemia. Leuk Lymphoma 1997 0.78
33 [Evolution of therapeutic practices and survival of ovarian cancer in Bourgandi between 1982-1996: a registry-based study]. Ann Chir 2004 0.78
34 Evidence for control of nitric oxide synthesis by intracellular transforming growth factor-beta1 in tumor cells. Implications for tumor development. Am J Pathol 1999 0.78
35 [Management of metastatic HER2-positive breast cancer: present and future]. Bull Cancer 2010 0.78
36 Carcinomatous Meningitis from Unknown Primary Carcinoma. Case Rep Oncol 2009 0.78
37 [Ganglioneuroblastoma in the adult]. Presse Med 1998 0.78
38 [Identification of basal-like carcinomas in clinical practice: "triple zero/BRCA1-like" carcinomas]. Bull Cancer 2010 0.77
39 Impact of immunohistochemical markers, CK5/6 and E-cadherin on diagnostic agreement in non-invasive proliferative breast lesions. Histopathology 2008 0.77
40 [Ductal in situ carcinoma: is it ethical to consider the breast conserving therapy as a standard?]. Cancer Radiother 2004 0.77
41 Nitric oxide inhibits proliferation but increases life-span of T lymphocytes in tumour-bearing rats. Cancer Immunol Immunother 1998 0.75
42 [Standards, options and recommendations: practice guidelines for difficult diagnosis in surgical pathology or cytopathology in cancer patients]. Bull Cancer 2001 0.75
43 [Conservative surgery in breast cancer: combination skin incision for a better cosmetic result]. Ann Chir 2004 0.75
44 [Dermoid cyst of the ovary. False positive diagnosis in iodine 131 scintigraphy of differentiated thyroid cancers]. Presse Med 1998 0.75
45 [Invasive adenocarcinoma with epidermoid carcinoma on the site of bladder exstrophy. Histochemical and immunocytochemical study]. Arch Anat Cytol Pathol 1991 0.75
46 Neoadjuvant therapy for breast cancer has no benefits on overall survival or on the mastectomy rate in routine clinical practice. A population-based study with a median follow-up of 11 years using propensity score matching. Eur J Cancer 2012 0.75
47 Impact of neoadjuvant chemotherapy on survival in breast cancer patients in daily practice: a population-based study. Eur J Cancer Care (Engl) 2013 0.75
48 [Histological and cytopathological cancer specimens: good practice in operating room]. Ann Chir 2003 0.75
49 Bone metastases from a melanoma of the anal verge. Rev Rhum Engl Ed 1998 0.75
50 Intravascular radiation and stenting: absence of efficacy on intimal proliferation in a rabbit model. Cardiovasc Drugs Ther 2000 0.75
51 [Uncommon cardiac manifestations disclosing pheochromocytoma. Apropos of 3 cases]. Ann Cardiol Angeiol (Paris) 1994 0.75
52 Preoperative radiotherapy and surgery for endometrial carcinoma: prognostic significance of the sterilization of the specimen. Int J Radiat Oncol Biol Phys 1998 0.75
53 [Amplification of c-myc and c-erbbeta-2(HER-2/neu) in breast cancer without axillary lymph node metastasis: correlation with other prognostic parameters]. Bull Cancer 1994 0.75
54 Absence of genetic abnormalities in fibroadenomas of the breast determined at p53 gene mutations and microsatellite alterations. Cancer Res 2001 0.75
55 [Regression of retroperitoneal fibrosis treated by tamoxifen]. Prog Urol 1996 0.75
56 Multifocal malignant fibrous histiocytoma of the spine. Rev Rhum Engl Ed 1997 0.75
57 Nasopharyngeal lymphomas: further evidence for a natural killer cell origin. Hum Pathol 1996 0.75
58 [Intrathoracic localisation of desmoid tumours: a familial case of isolated desmoid tumours and current published data]. Ann Chir 2006 0.75
59 [Lympho-epithelial lesions induced by plasma cells in a pulmonary MALT lymphoma]. Ann Pathol 1994 0.75